Loading
SSTR-positive gastroenteropancreatic NET after somatostatin analogue
| Drug | Dose | Route | Days | Note |
|---|---|---|---|---|
Lutetium-177 dotatate Radioligand therapy (beta) | 7.4 GBq | IV | D1 | with amino-acid infusion for renal protection |
Octreotide LAR Peptide hormone analogue (SSTR2 agonist) | 30 mg | SC | D1 | given after each dose; continue during and after treatment |
Reference doses for a typical adult from the cited protocol or label. Doses are adjusted for renal and hepatic function, age, performance status and prior toxicity, and institutional protocols vary. Verify against the current label and your local protocol before treating. Not medical advice.